Module 4: Invasive Aspergillosis
This learning activity has been designated to a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in this activity.
After completing this educational activity, the learner should be better able to:
Recognize the changing epidemiology and risk factors for invasive aspergillosis and the characteristics of Aspergillus species that cause infection
- Describe the pathogenesis of this infection
- Identify typical clinical manifestations and findings of invasive aspergillosis
- Utilize current diagnostic methods for establishing an early diagnosis and appropriate management strategies in aspergillosis
- Discuss approved prophylaxis strategies in patients at high risk for the development of invasive aspergillosis
- Review and apply approved treatment options and the role of antifungal prophylaxis in high-risk patient populations
Explain the potential development of the Immune Reconstitution Inflammatory Syndrome (IRIS) in patients with pulmonary aspergillus recovering from neutropenia.
This learning activity is intended for oncologists, hematologists, infectious disease specialists who treat transplant patients and other patient populations at risk for developing fungal infections.
Release Date: December 24, 2008
Expiration date: December 24, 2009
(*Please check this box to proceed - required)
Start the Module